Clinical Trial Update: Safety and Efficacy Study of DCVax-Direct in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and efficacy study of DCVax-Direct in solid tumors is being conducted by Northwest Biotherapeutics. The current status of the trial is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatocellular Carcinoma
• Melanoma
• Pancreatic Cancer

Drugs mentioned

• DCVax-Direct (DCVax-Direct)

Snippet

Sponsor: Northwest Biotherapeutics | Conditions: Locally Advanced Tumor, Metastatic Solid Tissue Tumors | Phase 1, Phase 2 | Status: UNKNOWN